2001 Nobel Prize in Physiology or Medicine — Hartwell, Hunt, and Nurse Uncover the Cell Cycle Scheduler

What You Will Learn in This Article

This article explains how the three 2001 Nobel laureates in Physiology or Medicine, Leland Hartwell, Tim Hunt, and Paul Nurse, elucidated the principles that control the cell cycle, the internal clock that determines when and how cells divide. Hartwell discovered CDC genes in yeast, genetically defining each stage of the cycle. Nurse demonstrated that one of these, cdc2, is a CDK (cyclin-dependent kinase) that is evolutionarily conserved up to humans. Hunt discovered cyclin, a signaling protein that turns CDK on and off in sea urchin eggs. When these three discoveries were combined, the cell cycle was accurately interpreted as a conditional scheduler in the OS kernel, and this map is the foundation for today's CDK inhibitors such as palbociclib and targeted cancer therapies.

A Different Perspective on Common Knowledge — Cells Do Not Decide on Their Own

The common understanding that "cells divide automatically when the time comes" is both right and wrong. The essence of "when the time comes" has been unclear for a long time. Until the mid-20th century, there were descriptive observations that the cell cycle consists of four stages: G1 (growth) → S (DNA replication) → G2 (preparation) → M (mitosis). However, for 30 years, the molecular answers to these three questions remained unsolved: what sends a signal to move from one stage to the next?, why do some cells stop and others continue to divide?, and what is wrong with cancer cells?

The discoveries of the three laureates can be summarized in a CS framework: the cell cycle is not an autonomous event loop, but an execution pipeline governed by a conditional scheduler. There are checkpoints (assertions) between each stage, and the next stage is only allowed to execute if the conditions are met. The kernel daemon that checks the conditions is CDK (cyclin-dependent kinase), the event signal that triggers the check is cyclin, and the fact that both are used once and then automatically degraded to prevent runaway behavior is a one-shot trigger that permeates the entire story.

In this framework, cancer takes on a new face. From the perspective that cancer is more of a scheduler disease than a genetic disease, cells with deactivated checkpoints, runaway cyclin, or missing CDK inhibitors continue to divide in a "build failed, but proceed to deploy" state.

The Zeitgeist — The New Millennium, the World is Shaking, and the Nobel Prize is Summarizing Its Own Century

2001 was a year when the crack between the 20th and 21st centuries became visible. In this year, the Nobel Foundation summarized the first century (1901-2001) of its founding and held the awards ceremony in Stockholm with special pomp. The series, which began with the first award (Behring in 1901), reached exactly 100 awards.

On September 11, the World Trade Center in New York collapsed. The United States, which had been celebrating the "end of history" after the end of the Cold War in the late 20th century, faced the beginning of a completely different century in its first year of the 21st century. The war in Afghanistan began immediately, and the biodefense budget of the National Institutes of Health (NIH) began to increase sharply. This trend, combined with the SARS outbreak a few years later, led to a major shift in infectious disease research. The atmosphere in Stockholm in December, when the Nobel Prize ceremony was held, was heavier than it had been a few months before.

Science, meanwhile, was moving towards a peak with its own rhythm. On February 15 and 16, Nature and Science simultaneously published the draft of the Human Genome Project. The map of 3 billion base pairs was printed for the first time, and researchers saw a new horizon: "Now that we know all the genes, the remaining task is to understand their function." At this moment, cell cycle research took on a special meaning. The controllers of the program that safely replicates and distributes the genome — namely CDK and cyclin — were the execution engines that actually transmitted the genome map across generations.

South Korea was moving beyond its establishment as an IT powerhouse. On March 29, Incheon International Airport opened, and the Kim Dae-jung administration continued to push for IT and biotechnology policies despite fatigue from the later stages of reform. The crisis at Hynix intensified, and the restructuring of the semiconductor industry began. Daewoo Motor was sold to GM. Although it was a period of adjustment after the venture boom, during this period, Korean life sciences began to enter the international trend of developing cell cycle-targeted anticancer drugs. Around this time, young Korean cell biologists began to introduce Hartwell and Nurse's methods into their laboratories.

The Human Story — Three Countries, Three Laboratories, One Map

The three laureates approached the problem from different countries, with different model organisms, and at different times. The fact that the results overlapped into one map is the most beautiful part of this story.

Leland Hartwell (1939~) was born in Minnesota, USA, received his Ph.D. from MIT, and spent his entire career at the Fred Hutchinson Cancer Research Center in Seattle. His strategy was a straightforward genetic approach. He used baker's yeast (Saccharomyces cerevisiae) — the yeast used to make bread and beer — to create a large number of mutants, and then selected strains that stopped at a specific point in the cell cycle. They grew normally at 30 degrees Celsius, but stopped dividing at 37 degrees Celsius. He named these temperature-sensitive mutants cdc (cell division cycle) genes. cdc1, cdc2, cdc4, ..., cdc28. In this way, he created a map of which gene was responsible for which decision at which point in the cycle. In particular, Hartwell introduced the concept of START — the point in late G1 where the cell finally decides "whether to enter this cycle."

Paul Nurse (1949~) was born in Norwich, England. His academic background was unconventional. He failed the French exam at Norwich City Grammar School and was unable to attend Oxford or Cambridge, and eventually went on to study biology at the University of Birmingham. Ph.D. from the University of East Anglia. His weapon was a different yeast, fission yeast (Schizosaccharomyces pombe). The name "pombe" comes from the name of the beer in which this yeast was discovered in East Africa. Nurse found cdc2 here, and it turned out to have a surprisingly similar function to Hartwell's cdc28. The key was in 1987. He found the equivalent of cdc2 in the human genome and inserted it into a fission yeast cdc2 knockout strain, and the normal cell cycle was restored. The fact that the components of two organisms that diverged 1.5 billion years ago were completely compatible with each other — the control of the cell cycle is a highly conserved principle. This man is the one who introduced CDK1 to the world.

Tim Hunt (1943~) was born in Westminster, England. He received his bachelor's and doctoral degrees from Cambridge University. Hunt's discovery came about by chance during a summer school. At the summer course at the Woods Hole Marine Biological Laboratory in the United States, he was working with sea urchin eggs for embryogenesis experiments and observed a strange phenomenon. By tracing protein synthesis with radioactively labeled amino acids, he found that a certain protein surged just before the M phase of the cell cycle and was completely degraded at the same time that the M phase entered. It was then synthesized and degraded again in the next cycle. Hunt named this self-destructive protein cyclin, meaning cyclical. 1982 paper. Later, it turned out that this protein was the partner that turns on CDK, which Hartwell and Nurse had discovered. If cyclin is not present, CDK is a dormant demon. When cyclin binds, it is activated and phosphorylates proteins necessary for initiating the next stage, changing their state.

At first, the three laboratories did not know much about each other. They spoke in their own languages from the American continent, Cambridge, and the Oxford-London academic circles, and from the late 1980s, the results began to fit together. Moments followed in which they said, "Your cdc2 was the partner of my cyclin" at conferences. In the 1990s, the integrated picture of cell cycle control was completed. The Nobel Committee waited until the end of the 20th century for the completion of this integration, and in the first year of the new century, awarded the prize to the three.

Key Achievements — The Cell Cycle Scheduler Seen Through a CS Framework

If you draw the cell cycle as a single pipeline, it looks like this:

• G1 (Growth 1): The stage in which the cell grows and gathers resources. The load sequence that checks for growth factors and nutrient status.
• S (Synthesis): DNA replication. The deployment stage that creates two copies of the entire genome.
• G2 (Growth 2): The health check that examines the damage and errors in the replicated DNA and prepares for mitosis.
• M (Mitosis): Mitosis. The dispatch that accurately divides the two copies of DNA and cell components into two daughter cells.

There are checkpoints (assertions) between these four stages:

• G1/S checkpoint (Restriction Point, START): "Is it okay to enter this cycle?" It verifies the presence of growth factor signals, the presence of DNA damage, and nutrient status. If the conditions are not met, the cell enters G0 (quiescent state) or undergoes apoptosis.
• G2/M checkpoint: "Has the DNA replication been completed and is there no damage?" If the check fails, it does not enter mitosis and waits or undergoes apoptosis.
• Spindle Assembly Checkpoint (SAC): During mitosis, are all chromosomes correctly attached to the spindle?

The CDK and cyclin are the execution engines of this pipeline.

CDK is the kernel scheduler daemon. It is always present in the cell, but is inactive on its own. Cyclin must bind to it to have a phosphate activity and phosphorylate the proteins necessary to initiate the next stage, changing their state. There are several types of CDKs in humans, and several types of cyclins, each of which is responsible for different stages. Roughly:

• Cyclin D + CDK4/6 → G1 progression
• Cyclin E + CDK2 → G1/S transition
• Cyclin A + CDK2 → S phase maintenance
• Cyclin B + CDK1 → G2/M transition and mitosis execution

Cyclin is a self-destructive event signal. It is synthesized explosively just before each stage and degraded immediately upon entry into the stage. This self-destruction is critical. The trigger that has been turned on must be turned off so that the next cycle can start at the correct time. It is the same principle as consuming event objects to prevent scheduler events from running repeatedly.

It should also be noted that this analogy has its limitations. In reality, cells are not purely deterministic schedulers, but systems with a significant amount of randomness. Even within the same tissue, some cells pass the START and others do not. Growth factor concentration, cell size, metabolic state, and contact inhibition with neighboring cells — all of these variables participate in the decision probabilistically. In other words, the CDK-cyclin system is an engine that executes decisions, but the decision itself is a probability function based on the accumulation of various signals. The OS scheduler analogy is only accurate for the execution mechanism.

Why It Matters: Cancer, Aging, and the Grammar of Targeted Therapies

With the completion of the map of cell cycle control, the definition of cancer was rewritten. Tumors are not so much a disease of genes, but rather a disease of the scheduler. While the causes are diverse, including radiation damage, chemicals, viruses, and genetic mutations, the ultimate result is a disruption in one or more of the following:

• Disabling of checkpoint assertions: For example, loss of the p53 tumor suppressor gene allows cells that should not pass the G1/S checkpoint to proceed. p53 is observed in a mutated state in half of human cancers.
• Cyclin-CDK runaway: Overexpression of Cyclin D, amplification of CDK4, and other factors cause the scheduler to continuously execute the next step, regardless of signals. This is a common pattern in breast cancer and melanoma.
• Blocking of cell death circuits: The apoptosis program, which should be activated upon checkpoint failure, is blocked by overexpression of Bcl-2 and other factors. This is a representative pattern in leukemia.

Based on this new framework, targeted anticancer drugs emerged in the early 21st century. A prime example is palbociclib, a CDK4/6 inhibitor. Approved by the FDA in 2015 for the treatment of breast cancer, this drug has shown remarkable efficacy in hormone receptor-positive breast cancer, where the Cyclin D-CDK4/6 axis is in a runaway state. Subsequent CDK inhibitors, such as ribociclib and abemaciclib, followed, and today, next-generation compounds targeting other CDKs, such as CDK7 and CDK9, are entering clinical trials. The grammar of all these drugs is based on the map created by Hartwell, Nurse, and Hunt.

Aging and regenerative medicine are also linked to this story. The fact that cells have an upper limit to the number of times they can safely divide (the Hayflick limit) is ultimately determined by cell cycle control and telomere management, which led to the 2009 Nobel Prize (Blackburn, Greider, Szostak). The Yamanaka factors, which create induced pluripotent stem cells (iPS), reset the cell cycle scheduler to its initial state (2012 Nobel Prize). The 2001 award served as the root for several Nobel stories in the following decade.

From an evolutionary perspective, the most remarkable thing is the conservation. Humans and yeast are separate lineages that diverged approximately 1.5 billion years ago, and CDK1, a key component of the cell cycle, can be exchanged between the two species and still function. This means that this system was completed very early in the evolution of eukaryotes, and its fundamental structure has hardly changed since then. The millions of cells in our bodies that we live with every day are dividing right now, using the same components that Hartwell and Nurse discovered in yeast. There are few indicators that more accurately show that humans are a part of the tree of life, as accurately as the list of cell cycle components.

The fact that the first Nobel Prize in Physiology or Medicine of the new millennium was awarded for this story was also a preview of where life sciences in the 21st century would be headed: from knowing individual molecules to designing and manipulating programs. These three individuals opened that door together.

→ Previous: 2000 Nobel Prize in Physiology or Medicine → Next: 2002 Nobel Prize in Physiology or Medicine